All posts

IMAX is a stock you should own in 2025: Roth

The content is coming and that’s one of the reasons you should own IMAX (IMAX Stock Quote, Chart, News, Analysts, Financials NYSE:IMAX).

So says Roth analyst Eric Handler, who in a research update to clients entitled “IMAX: Multiple Levers To Drive Growth In 2025”, named the stock his top small cap idea.

“The start of a strong 2+ year content cycle is at hand, in our view. Plus, we look for IMAX to further benefit from an expanding global footprint and a larger market share,” Handler argued. “Greater operational scale should also help drive EBITDA margin expansion. We see IMAX shares as inexpensive, at

Tagged with: imax
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Aurora Cannabis stock soars on Q3 results

If the pot stock trade is done, someone forget to tell Aurora Cannabis (Aurora Cannabis Stock Quote, Chart, News, Analysts,… [Read More]

1 day ago

Tantalus (TSX:GRID) has little exposure to tariffs, Paradigm says

The burgeoning tariff war has taken a bite out of Tantalus Systems (Tantalus Systems Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 days ago

Is Celestica still a buy?

The stock has been on fire since September, but Stifel analyst Ruben Roy thinks there is still money to be… [Read More]

2 days ago

WELL Health has a “giant” runway, Paradigm says

It's gone from zero to a billion in record time but there is plenty more runway for WELL Health Technologies… [Read More]

3 days ago

How will Bombardier handle tariffs?

The entire investing world right now is trying to figure out who will be most and least affected by the… [Read More]

3 days ago

Is beaten down PROF stock a buy now?

Buy the stock on weakness. That's the advice from Raymond James analyst Michael W. Freeman on Profound Medical Corp. (Profound… [Read More]

6 days ago